Variant report
Variant | esv3438292 |
---|---|
Chromosome Location | chr13:70259601-70261799 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528540707 | chr13:70259608-70259609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570336461 | chr13:70259628-70259629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546621188 | chr13:70259633-70259634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140283524 | chr13:70259650-70259651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572147606 | chr13:70259707-70259708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34085705 | chr13:70259713-70259714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188424787 | chr13:70259755-70259756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557385626 | chr13:70259794-70259795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565293391 | chr13:70259808-70259809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373754157 | chr13:70259853-70259854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs180904267 | chr13:70259873-70259874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185016442 | chr13:70260010-70260011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551258289 | chr13:70260024-70260025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76411941 | chr13:70260035-70260036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9572237 | chr13:70260138-70260139 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs192411071 | chr13:70260174-70260175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182086846 | chr13:70260185-70260186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530357588 | chr13:70260210-70260211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548799069 | chr13:70260231-70260232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548784097 | chr13:70260237-70260238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112021394 | chr13:70260238-70260239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528242398 | chr13:70260266-70260267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567398066 | chr13:70260268-70260269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564537321 | chr13:70260286-70260287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533387318 | chr13:70260290-70260291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550177343 | chr13:70260306-70260307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570398676 | chr13:70260315-70260316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199816343 | chr13:70260326-70260327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs199900222 | chr13:70260330-70260331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371734996 | chr13:70260335-70260336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377389101 | chr13:70260336-70260337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535765937 | chr13:70260352-70260353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141549503 | chr13:70260355-70260356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549603249 | chr13:70260371-70260372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138405969 | chr13:70260375-70260376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12560587 | chr13:70260408-70260409 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs201838918 | chr13:70260481-70260482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369366036 | chr13:70260482-70260483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369783981 | chr13:70260485-70260486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557590913 | chr13:70260503-70260504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71449295 | chr13:70260587-70260588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs28513760 | chr13:70260598-70260599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71116939 | chr13:70260611-70260612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28840800 | chr13:70260637-70260638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28853063 | chr13:70260639-70260640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201377153 | chr13:70260640-70260641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191621829 | chr13:70260661-70260662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182865358 | chr13:70260670-70260671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368117922 | chr13:70260675-70260676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372011851 | chr13:70260676-70260677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:70258200-70259800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr13:70258600-70259800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr13:70258600-70260000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:70258800-70263600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr13:70259400-70259800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr13:70259400-70259800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr13:70259400-70265000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr13:70259600-70260800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr13:70259800-70262200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:70259800-70264600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
11 | chr13:70259800-70264800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr13:70260000-70264600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr13:70260800-70261400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr13:70261400-70261800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |